Chromition

🔬🦠🧫 Thirty projects have received Innovate UK Biomedical Catalyst CR&D funding. Biomedical Catalyst is one of Innovate UK’s flagship grant funding mechanisms. It enables SMEs to test and develop innovative health and care solutions across health and life sciences, including therapeutics, medical devices, and digital health. The projects cover a wide range of health technologies including: 🔬Smart at-home predictive analytics 🔬Therapeutics for the treatment of a rare paediatric disease 🔬An immunotherapy platform for solid tumour 🔬A cell therapy for diabetic foot ulcers 🔬Improved specificity for T cells in ulcerative colitis 🔬A platform development for mRNA vaccines 🔬An ultrasonic scalpel driving system for robotic assisted surgery Examples include: SynaptixBio Ltd. will use its grant to develop the world’s first therapy to treat a rare paediatric neurodegenerative disorder, a type of leukodystrophy, for which there is currently no cure. Chromition hopes its Digital Rapid Autonomous Cancer Screening (DRACS) project will transform the way breast cancer is diagnosed. The project is being carried out with University of Manchester NHS Foundation Trust (Wythenshawe Hospital). SolasCure is developing Aurase Wound Gel, containing the enzyme Tarumase, to help remove dead skin and foreign materials, reduce bacterial buildup and promote wound bed preparation and healing. Its project aims to optimise the formulation of enzyme to ensure it can be shipped, stored and used efficiently, while ensuring the maximum amount of enzyme reaches the wound surface. Siloton’s personal Optical Coherence Tomography (OCT) system will enable patients with chronic retinal conditions to self-scan at home. This will mean treatment can be administered exactly when required, not just when patients are able to access a hospital OCT. Siloton will work with Bristol Eye Hospital on the project. Neuronostics has developed an algorithm that analyses electroencephalogram results to detect an epilepsy patient’s response to anti-seizure medications. The company is working with four NHS hospitals on the project and hopes the technology will improve patient outcomes. Read the full story here – https://ow.ly/L7cq50T4JSi The next round of Biomedical Catalyst CR&D funding will be launching in September. Sign up for updates from Innovate UK Business Connect on this and other health news 🗞️ - https://ow.ly/msCV50T4JS7 #BiomedicalCatalyst #Grants #Funding #Healthcare

NEWS: ‘Accelerating Research and Innovation in Greater Manchester’ 📈 A new report has been published celebrating the successes of the ERDF Research & Innovation (R&I) Health Accelerator from 2020-2023. The report reflects on the importance of partnership, highlights the levels of support and expertise received, and demonstrating how companies have been able develop their business as a result of this collaborative project. Read more here: https://ow.ly/LIPN50QFvzX #weareHInM #SME #Manchester #innovation #healthcare #medtech